29 May 2009
Two types of unsafe drinker judged to have metabolic syndrome: typical metabolic syndrome or alcohol-related syndrome?
Hirokazu YokoyamaABCDEFG, Hiroshi HiroseBDEF, Ikuo SaitoDEFGMed Sci Monit 2009; 15(6): PH57-64 :: ID: 869662
Abstract
Background
Hypertension, hyperlipidemia, and hyperglycemia often occur in drinkers regardless of obesity. Thus, the diagnostic criteria of metabolic syndrome (MS) may judge some drinkers as having MS even when typical MS is absent.
Material and Method
To verify this, 1,346 Japanese men aged 40 to 65 were divided into four groups based on their statuses of MS and drinking habits, and various parameters were compared among them. According to the suggestion of the Japanese Ministry of Health, Labour and Welfare, daily ethanol consumption up to 20 grams was defined as safe drinking.
Results
The serum adiponectin level was significantly higher in unsafe drinkers with MS than in those without it, whereas drinking habits were shown not to affect it. Among subjects judged to have MS, the ALT/AST ratio (ALT/AST) was the most effective parameter to distinguish between safe and unsafe drinkers. When unsafe drinkers with MS were classified into two subgroups by ALT/AST, i.e. that of > or =0.9 or <0.9, levels of ALT and adiponectin significantly differed between them and levels in the former and the latter subgroups were comparable to those in safe drinkers with MS and in unsafe drinkers without MS, respectively. Although the prevalence of MS was higher in unsafe drinkers than in safe drinkers, it became equivalent to each other when the latter subgroup was eliminated.
Conclusions
In drinkers who satisfy the diagnostic criteria of MS, subjects whose characteristics are different from those of typical MS, but comparable to those of alcohol-related syndrome, co-exist. This over-diagnosis is most likely due to ethanol consumption.
Keywords: Metabolic Syndrome X - pathology, Aspartate Aminotransferases - metabolism, Alcohol Drinking - pathology, Alanine Transaminase - metabolism, Adiponectin - metabolism, Safety
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Review article
Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.947124
Review article
Current Trends and Innovations in Oral and Maxillofacial ReconstructionMed Sci Monit In Press; DOI: 10.12659/MSM.947152
Clinical Research
The Role of the Vojta Method in Diagnosing and Enhancing Motor Skills in Preterm Infants: A Prospective Ope...Med Sci Monit In Press; DOI: 10.12659/MSM.945495
Clinical Research
Comparative Outcomes of Robot-Assisted vs Traditional Laparoscopic Ureteral Reimplantation for Lower Ureter...Med Sci Monit In Press; DOI: 10.12659/MSM.946803
Most Viewed Current Articles
17 Jan 2024 : Review article 7,354,048
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,440
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,976
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 22,314
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912